120 related articles for article (PubMed ID: 16602118)
1. Bone mineral density in children and young adults with beta-thalassemia major conventionally treated.
Christoforidis A; Hatzipantelis E; Tsatra I; Kazantzidou E; Katzos G; Athanassiou-Metaxa M
Pediatr Blood Cancer; 2006 Jul; 47(1):113-4; author reply 115. PubMed ID: 16602118
[No Abstract] [Full Text] [Related]
2. Bone mineral density in Iranian adolescents and young adults with beta-thalassemia major.
Shamshirsaz AA; Bekheirnia MR; Kamgar M; Pakbaz Z; Tabatabaie SM; Bouzari N; Pourzahedgilani N; Azarkeivan A; Hashemi SR; Moosavi F; Alebouyeh M; Vosough P; Kimiagar M; Shamshirsaz AA; Moradi M; Habibzadeh MR; Nobakhthaghighi N; Larijani B
Pediatr Hematol Oncol; 2007; 24(7):469-79. PubMed ID: 17786783
[TBL] [Abstract][Full Text] [Related]
3. The "lively" cytokines network in beta-Thalassemia Major-related osteoporosis.
Morabito N; Russo GT; Gaudio A; Lasco A; Catalano A; Morini E; Franchina F; Maisano D; La Rosa M; Plota M; Crifò A; Meo A; Frisina N
Bone; 2007 Jun; 40(6):1588-94. PubMed ID: 17412659
[TBL] [Abstract][Full Text] [Related]
4. The pattern of bone disease in transfusion-dependent thalassemia major patients.
Katz K; Horev G; Goshen J; Tamary H
Isr J Med Sci; 1994 Aug; 30(8):577-80. PubMed ID: 8045734
[TBL] [Abstract][Full Text] [Related]
5. Bone metabolism and mineral density in patients with beta-thalassemia major.
Dundar U; Kupesiz A; Ozdem S; Gilgil E; Tuncer T; Yesilipek A; Gultekin M
Saudi Med J; 2007 Sep; 28(9):1425-9. PubMed ID: 17768474
[TBL] [Abstract][Full Text] [Related]
6. Osteoprotegerin and RANKL in the pathogenesis of osteoporosis in patients with thalassaemia major.
Pietrapertosa AC; Minenna G; Colella SM; Santeramo TM; Renni R; D'Amore M
Panminerva Med; 2009 Mar; 51(1):17-23. PubMed ID: 19352306
[TBL] [Abstract][Full Text] [Related]
7. Osteoporosis in thalassemia major: an update and the I-CET 2013 recommendations for surveillance and treatment.
De Sanctis V; Soliman AT; Elsedfy H; Yassin M; Canatan D; Kilinc Y; Sobti P; Skordis N; Karimi M; Raiola G; Galati MC; Bedair E; Fiscina B; El Kholy M;
Pediatr Endocrinol Rev; 2013 Dec; 11(2):167-80. PubMed ID: 24575552
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis and management of osteoporosis in thalassemia.
Voskaridou E; Terpos E
Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():86-93. PubMed ID: 19337161
[TBL] [Abstract][Full Text] [Related]
9. High incidence of osteoporosis in thalassaemia major.
Jensen CE; Tuck SM; Agnew JE; Koneru S; Morris RW; Yardumian A; Prescott E; Hoffbrand AV; Wonke B
J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():975-7. PubMed ID: 10091176
[No Abstract] [Full Text] [Related]
10. Effect of zoledronic acid on markers of bone turnover and mineral density in osteoporotic patients with beta-thalassaemia.
Perifanis V; Vyzantiadis T; Tziomalos K; Vakalopoulou S; Garipidou V; Athanassiou-Metaxa M; Harsoulis F
Ann Hematol; 2007 Jan; 86(1):23-30. PubMed ID: 17013645
[TBL] [Abstract][Full Text] [Related]
11. Markers of bone metabolism in eugonadal female patients with beta-thalassemia major.
Angelopoulos NG; Goula A; Katounda E; Rombopoulos G; Kaltzidou V; Kaltsas D; Konstandelou E; Tolis G
Pediatr Hematol Oncol; 2007; 24(7):481-91. PubMed ID: 17786784
[TBL] [Abstract][Full Text] [Related]
12. Effect of bisphosphonate treatment on bone mineral density in patients with thalassaemia major.
Skordis N; Ioannou YS; Kyriakou A; Savva SC; Efstathiou E; Savvides I; Christou S
Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():144-8. PubMed ID: 19337169
[TBL] [Abstract][Full Text] [Related]
13. Osteoporosis in beta-thalassemia: Clinical and genetic aspects.
Origa R; Fiumana E; Gamberini MR; Armari S; Mottes M; Sangalli A; Paglietti E; Galanello R; Borgna-Pignatti C
Ann N Y Acad Sci; 2005; 1054():451-6. PubMed ID: 16339696
[TBL] [Abstract][Full Text] [Related]
14. Bone mineral density in beta-thalassemia major and intermedia.
Karimi M; Ghiam AF; Hashemi A; Alinejad S; Soweid M; Kashef S
Indian Pediatr; 2007 Jan; 44(1):29-32. PubMed ID: 17277428
[TBL] [Abstract][Full Text] [Related]
15. Bone density study of thalassemic patients from Reggio Calabria Province.
D'Ascola DG; Caminiti M; Mariano GP; Giuffrè C; Parlongo S; Meduri P; Brugiatelli M
J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():963-4. PubMed ID: 10091173
[No Abstract] [Full Text] [Related]
16. Growth in children after bone marrow transplantation for thalassemia.
Gaziev J; Galimberti M; Giardini C; Baronciani D; Lucarelli G
Bone Marrow Transplant; 1993; 12 Suppl 1():100-1. PubMed ID: 8374543
[No Abstract] [Full Text] [Related]
17. Osteoporosis and osteosclerosis in sickle cell/beta-thalassemia: the role of the RANKL/osteoprotegerin axis.
Voskaridou E; Stoupa E; Antoniadou L; Premetis E; Konstantopoulos K; Papassotiriou I; Terpos E
Haematologica; 2006 Jun; 91(6):813-6. PubMed ID: 16704959
[TBL] [Abstract][Full Text] [Related]
18. Case control study of psychosocial morbidity in beta thalassemia major.
Saini A; Chandra J; Goswami U; Singh V; Dutta AK
J Pediatr; 2007 May; 150(5):516-20. PubMed ID: 17452227
[TBL] [Abstract][Full Text] [Related]
19. Is beta-thalassemia trait a risk factor for developing depression in young adults?
Marvasti VE; Dastoori P; Karimi M
Ann Hematol; 2006 Dec; 85(12):873-4. PubMed ID: 16845515
[No Abstract] [Full Text] [Related]
20. Study of bone density by pQCT analysis in healthy adults and patients with B-thalassemia major and intermedia.
Ladis V; Raptou P; Rigatou E; Chouliaras G; Galanos A; Korres D; Kattamis C
Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():127-31. PubMed ID: 19360988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
